These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33979843)

  • 1. Homeopathic Treatment in Patients with Polycystic Ovarian Syndrome: A Case Series.
    Parveen S; Das S
    Homeopathy; 2021 Aug; 110(3):186-193. PubMed ID: 33979843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic Ovarian Syndrome Treated with Individualized Homeopathy: A Case Report.
    Lamba P; Sharma D; Sinnarkar VV
    Altern Ther Health Med; 2022 Sep; 28(6):60-64. PubMed ID: 34653021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive Resolution of Pathological Ovarian Masses with Homeopathic Treatment-A Case Series.
    Ramanan VE; Radhakrishnan R
    Homeopathy; 2022 Aug; 111(3):194-201. PubMed ID: 34959245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire.
    Bazarganipour F; Ziaei S; Montazeri A; Faghihzadeh S; Frozanfard F
    Hum Reprod; 2012 Sep; 27(9):2729-36. PubMed ID: 22740491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligoovulatory and anovulatory cycles in women with polycystic ovary syndrome (PCOS): what's the difference?
    Burgers JA; Fong SL; Louwers YV; Valkenburg O; de Jong FH; Fauser BC; Laven JS
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E485-9. PubMed ID: 20843954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovaries and associated clinical and biochemical features in young women.
    Michelmore KF; Balen AH; Dunger DB; Vessey MP
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):779-86. PubMed ID: 10619984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Co-morbid Condition of Warts and Vitiligo Treated with Individualized Homeopathy: An Evidence-Based Case Report.
    Prusty AK; Bhandari P
    Homeopathy; 2022 May; 111(2):139-146. PubMed ID: 34820793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E; Kunicki M; Radowicki S
    Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C; Fanelli F; Pariali M; Zanotti L; Gambineri A; Pasquali R
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1575-82. PubMed ID: 23928669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.